Skip to content

Chronic Lymphocytic Leukaemia in Combination with Obinutuzumab in Adult Patients with Previously Untreated Disease

Living with Chronic Lymphocytic Leukaemia in Combination with Obinutuzumab in Adult Patients with Previously Untreated Disease means managing a challenging set of symptoms. This page lists medicine types such as Ibrutinib that may be part of a wider care strategy. Products containing Ibrutinib feature in this group.

Ibrutinib Capsules

Ibrutinib

140mg

Treats certain blood cancers by blocking Bruton's tyrosine kinase, a protein essential for b-cell cancer cell survival and proliferation, resulting to reduced tumour burden.

From$23.83/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.